AUTHOR=Easom Nicholas J. W. , Marks Michael , Jobe Dawda , Gillmore Roopinder , Meyer Tim , Maini Mala K. , Njie Ramou TITLE=ULBP1 Is Elevated in Human Hepatocellular Carcinoma and Predicts Outcome JOURNAL=Frontiers in Oncology VOLUME=10 YEAR=2020 URL=https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2020.00971 DOI=10.3389/fonc.2020.00971 ISSN=2234-943X ABSTRACT=
Hepatocellular carcinoma (HCC) remains a leading cause of cancer death worldwide, and despite recent immunotherapeutic advances there remains a need for improved diagnostic, prognostic, and therapeutic tools. UL-16 binding protein 1 (ULBP1) is a ligand of the activatory receptor Natural Killer cell Group 2 receptor D (NKG2D) and is found as a cell-surface protein on some malignant cells including on human hepatocellular carcinomas. We aimed to explore the biological and clinical significance of NKG2D ligands in the circulation of patients with HCC. We measured ULBP1 in the serum of two retrospective cohorts of patients with HCC from the PROLIFICA cohort in The Gambia (